After completing this case study, the reader should be able to:
Identify risk factors associated with stress gastritis/ulceration and determine which critically ill patients should receive pharmacologic prophylaxis.
Recommend appropriate pharmacologic alternatives including agent, route of administration, and dose for the prevention of stress–induced gastritis/ulceration.
Identify and implement monitoring parameters for the recommended stress gastritis/ulceration prophylactic regimens.
Discuss the pharmacologic approaches to the management of stress ulcer–induced bleeding.
No complaint—patient is unresponsive.
Penny Robinson is a 26-year-old woman who presents to the ED with traumatic injuries following a motor vehicle accident. She was the restrained driver of a car who was hit on the driver’s side by a tractor-trailer that ran a red light. When EMS arrived in the field, the patient was unresponsive with labored breathing. She was given fentanyl 50 mcg, succinylcholine 40 mg, midazolam 5 mg, and was intubated prior to transfer to the hospital. The EMS report indicates that the intubation was very difficult. The extraction time from the vehicle to the ED was 25 minutes.
PMH (Provided by Patient’s Mother)
Both mother and father are still alive and in “good health.”
Patient is a graduate student at a local university. She smoked cigarettes 1 ppd × 6 years until she was hospitalized for a PE and has since quit. She does not drink alcohol or use illicit drugs.
Patient is unresponsive after an MVA
Norethindrone 0.35 mg PO daily
Lubiprostone 24 mcg PO Q 12 H
Rivaroxaban 20 mg PO daily
Young, unresponsive woman; no obvious bleeding on exam
BP 108/68, P 106, RR 24, T 37.3°C; Wt 51 kg, Ht 5′11″
Warm, dry; small lacerations across forehead and chest; ecchymoses present on both legs and arms
Supple, no palpable areas of deformity or masses
No blood visible in the nose or ears; no obvious damage to the ears, eyes, or nose
S1, S2 normal; sinus tachycardia with no S3, S4